Role of endothelial MCP-1 in monocyte adhesion to inflamed human endothelium under physiological flow

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 6 52-6, 2002, Pages

  Maus, U ^a   Henning, S ^b   Wenschuh, H ^a   Mayer, K ^a   Seeger, W ^b   Lohmeyer, J ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Jerini AG   (Germany)

Author keywords

Adhesion molecules; Cell trafficking; Chemokines; Monocyte chemoattractant protein 1; Monocytes macrophages

Indexed keywords

BETA1 INTEGRIN; BETA2 INTEGRIN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR2; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD FLOW; CHEMOTAXIS; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ADHERENCE; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY ARTERY; RNA TRANSLATION; SHEAR FLOW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0036889547     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00349.2002     Document Type: Article

References (29)

1. 2 integrins on T lymphocytes. Immunity 4: 179-187, 1996.
2. Dransfield I, Cabañas C, Craig A, and Hogg N. Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 116: 219-226, 1992.
3. 2+ binding epitope on leukocyte integrin α subunits. EMBO J 8: 3759-3765, 1989.
4. Fuentes ML, Durham SK, Swerdel MR, Lewin AC, Barton DS, Megill JR, Bravo R, and Lira SR. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 155: 5769-5776, 1995.
5. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, and Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718-723, 1999.
6. 2-terminal residues. J Exp Med 181: 631-640, 1995.
7. Gong JH, Ratkay LG, Waterfield JD, and Clark-Lewis I. An antagonist of monocyte chemoattractant protein-1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 186: 131-137, 1997.
8. Grewal IS, Rutledge BJ, Fiorillo JA, Gu L, Gladue RP, Flavell RA, and Rollins BJ. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes-abrogation by a second transgene expressing systemic MCP-1. J Immunol 159: 401-408, 1997.
9. Gunn MD, Nelken NA, Liao X, and Williams LT. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 158: 376-383, 1997.
10. Huo Y, Weber C, Forlow SB, Sperandio M, Thatte J, Mack M, Jung S, Littman DR, and Ley K. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest 108: 1307-1312, 2001.
11. Jaffe EA, Nachmann RL, Becker CG, and Mimnick CR. Culture of human endothelial cells derived from umbilical veins. Identification of morphologic and immunologic criteria. J Clin Invest 52: 2745-2750, 1973.
12. Janatpour MJ, Hudak S, Sathe M, Sedgwick JD, and McEvoy LM. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J Exp Med 193: 1375-1384, 2001.
13. Kimura H, Okada O, Tanabe N, Tanaka Y, Terai M, Takiguchi Y, Masuda M, Nakajima N, Hiroshima K, Inadera H, Matsushima K, and Kuriyama T. Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 164: 319-324, 2001.
14. Kukreti SK, Konstantopoulos K, Smith CW, and McIntire LV. Molecular mechanisms of monocyte adhesion to interleukin-1β-stimulated endothelial cells under physiologic flow conditions. Blood 89: 4104-4111, 1997.
15. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, and Maeda N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 94: 12053-12058, 1997.
16. Luscinskas FW, Gerszten RE, Garcia-Zepeda EA, Li YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, and Rosenzweig A. C-C- and C-X-C chemokines trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Ann NY Acad Sci 902: 288-293, 2000.
17. Maus U, Herold S, Muth H, Maus R, Ermert L, Ermert M, Weissmann N, Rosseau S, Seeger W, Grimminger F, and Lohmeyer J. Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am J Physiol Lung Cell Mol Physiol 280: L58-L68, 2001.
18. Maus U, Herold S, Schlingensiepen KH, Schlingensiepen R, Dormayr T, Rosseau S, Maus R, Seeger W, and Lohmeyer J. Antisense oligomers for selective suppression of MCP-1 synthesis in human pulmonary endothelial cells. Antisense Nucleic Acid Drug Dev 10: 185-193, 2000.
19. Maus U, Huwe J, Maus R, Seeger W, and Lohmeyer J. Alveolar JE/MCP-1 and endotoxin synergize to provoke lung cytokine upregulation, sequential neutrophil and monocyte influx, and vascular leakage in mice. Am J Respir Crit Care Med 164: 406-411, 2001.
20. Maus U, Rosseau S, Mandrakas N, Schlingensiepen R, Maus R, Muth H, Grimminger F, Seeger W, and Lohmeyer J. Cationic lipids employed for antisense oligodeoxynucleotide transport may inhibit vascular cell adhesion molecule-1 expression in human endothelial cells-a word of caution. Antisense Nucleic Acid Drug Dev 9: 71-80, 1999.
21. Maus U, Seeger W, and Lohmeyer J. Impact of a phosphorothioate oligodeoxynucleotide MCP-1 on NF-κB, AP-1, and Sp1, and the NF-κB and AP-1 subunit-composition in human pulmonary endothelial cells. Antisense Nucleic Acid Drug Dev 11: 59-64, 2001.
22. Moore TM, Chetham PM, Kelly JJ, and Stevens T. Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP. Am J Physiol Lung Cell Mol Physiol 275: L203-L222, 1998.
23. Nasreen N, Mohammed KA, Galffy G, Ward MJ, and Antony WB. MCP-1 in pleural injury: CCR2 mediates haptotaxis of pleural mesothelial cells. Am J Physiol Lung Cell Mol Physiol 278: L591-L598, 2000.
24. Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, Dorf M, Littman DR, Rollins BJ, Zweerink H, Rot A, and von Andrian UH. Inflammatory chemokine transport and presentation in HEV: A remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 194: 1361-1373, 2001.
25. Randolph GJ and Furie MB. A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. J Immunol 155: 3610-3618, 1995.
26. Stevens T, Creighton J, and Thompson WJ. Control of cAMP in lung endothelial cell phenotypes. Implications for control of barrier function. Am J Physiol Lung Cell Mol Physiol 277: L119-L126, 1999.
27. 2 integrin avidity by chemoattractants in eosinophils. Proc Natl Acad Sci USA 93: 10939-10944, 1996.
28. 2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the α subunit cytoplasmic domains. Mol Biol Cell 10: 861-873, 1999.
29. Weber KSC, von Hundelshausen P, Clark-Lewis I, Weber PC, and Weber C. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur J Immunol 29: 700-712, 1999.